Navigation Links
BioMarin Announces Third Quarter 2009 Financial Results
Date:10/28/2009

----- -- ----- ----- Total operating expenses 70,295 70,674 189,517 227,529 ------ ------ ------- ------- Income (loss) from operations 2,351 10,133 7,700 10,045 Equity in the loss of BioMarin/Genzyme LLC (572) (680) (1,692) (1,773) Interest income 3,407 1,012 13,157 4,051 Interest expense (4,105) (2,880) (12,297) (11,375) Impairment loss on equity investments - - - (5,848) Net gain from sale of investments - - - 1,585 --- --- --- ----- Income (loss) before income taxes 1,081 7,585 6,868 (3,315) Provision for income taxes 252 945 543 1,884 --- --- --- ----- Net income (loss) $829 $6,640 $6,325 $(5,199) ==== ====== ====== ======= Net income (loss) per share, basic $0.01 $0.07 $0.06 $(0.05) ===== ===== ===== ====== Net income (loss) per share, diluted $0.01 $0.06 $0.06 $(0.05) ===== ===== ===== ====== Weighted average common shares outstanding, basic 99,537 100,331 98,705 100,098 ====== ======= ====== ======= Weighted average common shares outstanding, diluted 103,403 101,906 103,916 100,189 ======= ==
'/>"/>
SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. BioMarin to Present at the Oppenheimer Healthcare Conference
2. BioMarin Acquires Huxley Pharmaceuticals, Inc.
3. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
4. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
5. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
6. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
7. BioMarin Announces FDA Approval for Kuvan
8. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
9. Rigel Announces Presentations at Two Investor Conferences
10. Onyx Pharmaceuticals Announces Third Quarter 2009 Financial Results Teleconference and Webcast
11. STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... from institutional investors to purchase an aggregate of approximately ... at-the-market registered direct offering, led by a dedicated health ... purchase agreements with these investors pursuant to which the ...
(Date:1/15/2014)... Jan. 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, ... the Journal of Drugs in Dermatology (JDD) ... (ODAC). The event is January 17-20, 2014, at the Omni Orlando ... The ODAC is a distinguished event ...
(Date:1/15/2014)... PALM BEACH GARDENS, Fla. , Jan. 15, 2014  In an ... C. difficile and TB in ambulances and other transport vehicles, an ... being used by rescue personnel for the first time. ... coming in contact with these deadly pathogens, West Palm ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Superbugs No Longer Ride In Rescue Vehicles 2
(Date:4/24/2014)... Philadelphia, Pa. (April 24, 2014) - Contact lenses coated with ... contact lens-related infections, reports a study in Optometry ... American Academy of Optometry . The journal is published ... Wolters Kluwer Health . , Studies in animals and ... with the antimicrobial peptide melimine, according to the new research ...
(Date:4/24/2014)... irrelevant, could offer an alternative to heart transplants for ... and her team from the Australian Regenerative Medicine Institute ... is a close relative to a cardiomyocyte, the cell ... published today in Circulation Research , Dr Furtado ... to their genetic program, and will aid in the ...
(Date:4/24/2014)... researchers was the first in the world to discover ... of the jaw. , Ameloblastoma is an odontogenic tumour ... is most often found in the posterior of the ... in tissue deficiencies in the jaws as well as ... reduce the need for surgery and the recurrence of ...
(Date:4/24/2014)... by a scientist at the University of York reveals ... the development of the nervous system may also play ... A research team, led by Dr Will Brackenbury, ... Biology at York, has studied how voltage-gated sodium channels ... are found in the membranes of excitable cells, such ...
(Date:4/23/2014)... SPOKANE, Wash.Researchers at Washington State University Spokane have ... are about to nod off behind the wheel. ... steering wheel movementswhich are more variable in drowsy ... to currently available video-based driver drowsiness detection systems. ... detect when a car is drifting out of ...
Breaking Medicine News(10 mins):Health News:Study supports safety of antimicrobial peptide-coated contact lenses 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 3Health News:Boring cells could hold the key to heart disease 2Health News:Breast cancer replicates brain development process 2Health News:WSU innovation improves drowsy driver detection 2
... Va., Aug. 21, 2008 The AMERIGROUP,Foundation today ... has,been honored with its "Champion for Children" award., ... Foundation,s national program,recognizing outstanding public advocacy efforts by ... well-being of children throughout our,nation., "Our goal ...
... & CEO of Blue Shield of California will participate ... Health, Wellness and,Prevention at the start of the Democratic ... at Boettcher Hall in the Denver Performing,Arts Complex. Mr. ... reform, and the ways in which health plans work ...
... 21 L.A. Care Health Plan,announced today that it ... National Committee for Quality Assurance (NCQA), an,independent, non-profit organization ... managed care plans. L.A. Care,s Accreditation,status - the highest ... of how,a health plan ensures that its members are ...
... Calif., Aug. 21 The Pancreatic Cancer,Action Network ... in a comprehensive way through research, patient support,community ... by the loss of NFL,Hall of Fame member ... offers its condolences to the,Upshaw family and the ...
... A universal vaccine effective against several strains of ... to Dr. Christine Turley of the University of Texas ... trials and clinical research at the Sealy Center for ... said that VaxInnate,s M2e universal vaccine could possibly protect ...
... have evolutionary distaste for bitter remedies, foods, study finds ... your child won,t take medicine and shuns broccoli at ... to respond that way. , "Kids reject the bad ... system is designed to reject that taste, because many ...
Cached Medicine News:Health News:Texas State Rep. Sylvester Turner Honored as 'Champion for Children' by The AMERIGROUP Foundation 2Health News:Blue Shield of California CEO to Speak at Democratic Convention Host Committee's Health Roundtable in Denver 2Health News:NCQA Awards L.A. Care Health Plan Its Highest Accreditation Status of Excellent 2Health News:The Pancreatic Cancer Action Network is Saddened by the Death of NFL Hall of Fame Member Gene Upshaw 2Health News:Spoonful of Sugar Really Might Help Medicine Go Down 2Health News:Spoonful of Sugar Really Might Help Medicine Go Down 3